NASDAQ: PODD - Insulet Corporation

Yield per half year: +44.67%
Dividend yield: 0.00%
Sector: Healthcare

Company Analysis Insulet Corporation

Download the report: word Word pdf PDF

1. Summary

Advantages

  • The stock's return over the last year (43.43%) is higher than the sector average (-12.5%).
  • Current debt level 54.84% is below 100% and has decreased over 5 years from 77.69%.
  • The company's current efficiency (ROE=28.16%) is higher than the sector average (ROE=9.61%)

Disadvantages

  • Price (271.83 $) is higher than fair price (55.42 $)
  • Dividends (0%) are below the sector average (0.541%).

Similar companies

Alexion

Amgen

ABIOMED

Gilead Sciences

2. Share price and performance

2.1. Share price

2.2. News

No news yet

2.3. Market efficiency

Insulet Corporation Healthcare Index
7 days 1.6% 2.5% -1.6%
90 days 20% -17.8% 7.4%
1 year 43.4% -12.5% 26.7%

PODD vs Sector: Insulet Corporation has outperformed the "Healthcare" sector by 55.93% over the past year.

PODD vs Market: Insulet Corporation has outperformed the market by 16.75% over the past year.

Stable price: PODD is not significantly more volatile than the rest of the market on "NASDAQ" over the last 3 months, with typical variations of +/- 5% per week.

Long period: PODD with weekly volatility of 0.8352% over the past year.

3. Summary of the report

3.1. General

P/E: 77.16
P/S: 9.38

3.2. Revenue

EPS 2.8
ROE 28.16%
ROA 7.97%
ROIC 5.25%
Ebitda margin 12.96%

4. Fundamental Analysis

4.1. Stock price and price forecast

The fair price is calculated taking into account the Central Bank refinancing rate and earnings per share (EPS)

Above fair price: The current price (271.83 $) is higher than the fair price (55.42 $).

Price is higher than fair: The current price (271.83 $) is 79.6% higher than the fair price.

4.2. P/E

P/E vs Sector: The company's P/E (77.16) is higher than that of the sector as a whole (48.77).

P/E vs Market: The company's P/E (77.16) is higher than that of the market as a whole (49.04).

4.2.1 P/E Similar companies

4.3. P/BV

P/BV vs Sector: The company's P/BV (21.73) is higher than that of the sector as a whole (4.83).

P/BV vs Market: The company's P/BV (21.73) is higher than that of the market as a whole (3.17).

4.3.1 P/BV Similar companies

4.4. P/S

P/S vs Sector: The company's P/S indicator (9.38) is lower than that of the sector as a whole (33.77).

P/S vs Market: The company's P/S indicator (9.38) is lower than that of the market as a whole (10.24).

4.4.1 P/S Similar companies

4.5. EV/Ebitda

EV/Ebitda vs Sector: The company's EV/Ebitda (75.98) is higher than that of the sector as a whole (-22.17).

EV/Ebitda vs Market: The company's EV/Ebitda (75.98) is higher than that of the market as a whole (28.32).

5. Profitability

5.1. Profitability and revenue

5.2. Earnings per share - EPS

5.3. Past profitability Net Income

Yield Trend: Rising and has grown by 667.67% over the last 5 years.

Earnings Slowdown: The last year's return (0%) is below the 5-year average return (667.67%).

Profitability vs Sector: The return for the last year (0%) is lower than the return for the sector (4135.44%).

5.4. ROE

ROE vs Sector: The company's ROE (28.16%) is higher than that of the sector as a whole (9.61%).

ROE vs Market: The company's ROE (28.16%) is higher than that of the market as a whole (10.71%).

5.5. ROA

ROA vs Sector: The company's ROA (7.97%) is higher than that of the sector as a whole (0.3443%).

ROA vs Market: The company's ROA (7.97%) is higher than that of the market as a whole (6.47%).

5.6. ROIC

ROIC vs Sector: The company's ROIC (5.25%) is lower than that of the sector as a whole (7.63%).

ROIC vs Market: The company's ROIC (5.25%) is lower than that of the market as a whole (10.79%).

6. Finance

6.1. Assets and debt

Debt level: (54.84%) is quite low in relation to assets.

Debt reduction: over 5 years, the debt has decreased from 77.69% to 54.84%.

Excess of debt: The debt is not covered by net income, percentage 687.98%.

6.2. Profit growth and share price

7. Dividends

7.1. Dividend yield vs Market

Low yield: The dividend yield of the company 0% is below the average for the sector '0.541%.

7.2. Stability and increase in payments

Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.

Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.

7.3. Payout percentage

Dividend Coverage: Current payments from income (5.14%) are at an uncomfortable level.

8. Insider trades

8.1. Insider trading

Insider Selling More insider purchases by 100% over the last 3 months.

8.2. Latest transactions

Transaction date Insider Type Price Volume Quantity
12.11.2024 BORIO LUCIANA
Director
Sale 274.8 139 598 508
09.09.2024 Budden Lauren
Group VP, CAO and Controller
Sale 221.41 333 443 1 506
09.09.2024 Field Mark N
SVP & Chief Technology Officer
Sale 220.87 305 463 1 383
28.08.2024 Field Mark N
SVP & Chief Technology Officer
Sale 203 281 561 1 387
28.08.2024 Field Mark N
Officer
Purchase 203 281 561 1 387

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

9. Stocks forum Insulet Corporation

9.3. Comments